{
    "nct_id": "NCT00368459",
    "title": "Raloxifene in Women With AD: Randomized Controlled Trial",
    "status": "COMPLETED",
    "last_update_time": "2015-03-20",
    "description_brief": "This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.",
    "description_detailed": "Raloxifene , a selective estrogen receptor modulator, has attracted attention as a potential treatment for Alzheimer's disease in women, but it has not been studied in this disorder.\n\nTo assess feasibility of large-scale efficacy trials and to obtain an initial estimate of treatment effect, study investigators plan to conduct a pilot, randomized, double blind, placebo-controlled, clinical trial of high-dose (120 mg daily) raloxifene. Eligible participants are postmenopausal women with late-onset Alzheimer's disease of mild-to-moderate severity taking a stable dose of an approved cholinesterase inhibitor. This pilot study is not designed to have power to detect significant, modest between-group differences of the magnitude provided by current FDA-approved therapies.\n\nStudy participants will be randomly allocated to oral raloxifene or identical placebo over a 12 month period. Outcomes of interest will be obtained at 6 and 12 months. The prespecified primary outcome is the change in the Alzheimer's Disease Assessment Scale, cognitive subscale (ADAS-cog), compared between groups at 12 months. Prespecified secondary outcomes include measures of global severity (Clinical Dementia Rating sum of boxes), function (Activities of Daily Living), behavior (Neuropsychiatric inventory), and other neuropsychological measures. Caregiver outcomes will be burden (Zarit burden inventory) and distress (from the Neuropsychiatric inventory).",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Raloxifene",
                    "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "identical appearing oral placebo"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "21"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "21"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "19"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "20"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "Postmenopausal women with Alzheimer's disease of mild to moderate severity",
            "groups": [
                {
                    "id": "BG000",
                    "title": "Raloxifene",
                    "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "identical appearing oral placebo"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "21"
                        },
                        {
                            "groupId": "BG001",
                            "value": "21"
                        },
                        {
                            "groupId": "BG002",
                            "value": "42"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "78",
                                            "spread": "4.5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "74",
                                            "spread": "5.1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "76",
                                            "spread": "4.8"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "42"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "42"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "41"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "42"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-cog)",
                    "description": "ADAS-cog, change from baseline at 12 months, compared between treatment arms. The ADAS-cog is a neuropsychological battery commonly used in trials of AD patients. Error score range 0-70. For results below, positive change represents improvement/ better performance.\n\nFor the primary outcome, as well as for secondary outcomes, the reported p-values reflect the calculated p-values.",
                    "populationDescription": "Intent-to-treat",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.2",
                                            "spread": "5.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-3.5",
                                            "spread": "8.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For this pilot trial, we did not anticipate power to detect significant, clinically-meaningful between-group differences of the magnitude provided by FDA-approved AD therapies over a 12 month treatment period, but we specified that we would report trends (alpha \\<0.1) as a guide to future effectiveness studies.",
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Global Rating, Clinical Dementia Rating (CDR) Sum of Boxes",
                    "description": "Global rating of dementia severity, change from baseline at 12 months. Range 0-5. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.6",
                                            "spread": "1.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.0",
                                            "spread": "3.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Function, Activities of Daily Living (ADL)",
                    "description": "ADL scale from the Alzheimer's Disease Cooperative Study, change from baseline at 12 months. Range 0-78. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-9.1",
                                            "spread": "9.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-4.5",
                                            "spread": "9.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Behavior",
                    "description": "Neuropsychiatric Inventory, change from baseline at 12 months. Range 0-120. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.3",
                                            "spread": "7.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.5",
                                            "spread": "6.3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognitive (Neuropsychological)",
                    "description": "Global composite calculated as a weighted average of standardized scores of neuropsychological tests (weighted by the inverse intertest correlation matrix), change from baseline at 12 months. There is no theoretical maximum or minimum for this cognitive composite, with a score of 0 standardized units representing no change. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.6",
                                            "spread": "1.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.1",
                                            "spread": "1.4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "ADAS-cog",
                    "description": "Change from baseline at 6 months, compared between groups. Error score range 0-70. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.7",
                                            "spread": "4.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.8",
                                            "spread": "6.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinical Dementia Rating, Sum of Boxes",
                    "description": "Change from baseline at 6 months, compared between groups. Range 0-5. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.8",
                                            "spread": "1.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.0",
                                            "spread": "2.4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Function, Activities of Daily Living",
                    "description": "Change from baseline at 6 months, compared between groups. Range 0-78. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-6.9",
                                            "spread": "6.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.3",
                                            "spread": "5.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "<0.01",
                            "pValueComment": "Favoring placebo, unadjusted for multiple comparisons",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Behavior",
                    "description": "Neuropsychiatric Inventory, change from baseline at 6 months, compared between groups. Range 0-120. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.7",
                                            "spread": "5.6"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.1",
                                            "spread": "8.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition (Neuropsychological)",
                    "description": "Global composite calculated as a weighted average of standardized scores of neuropsychological tests (weighted by the inverse intertest correlation matrix), change from baseline at 6 months. There is no theoretical maximum or minimum for this cognitive composite, with a score of 0 standardized units representing no change. For results below, positive change represents improvement/ better performance.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Raloxifene",
                            "description": "oral raloxifene 120 mg once daily\n\nraloxifene"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "identical appearing oral placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.5",
                                            "spread": "1.5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.6",
                                            "spread": "1.1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": ">0.1",
                            "statisticalMethod": "ANCOVA",
                            "ciNumSides": "TWO_SIDED"
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Raloxifene",
                    "description": "oral raloxifene 120 mg once daily\n\nraloxifene",
                    "seriousNumAffected": 2,
                    "seriousNumAtRisk": 21,
                    "otherNumAffected": 16,
                    "otherNumAtRisk": 21
                },
                {
                    "id": "EG001",
                    "title": "Placebo",
                    "description": "identical appearing oral placebo",
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 21,
                    "otherNumAffected": 13,
                    "otherNumAtRisk": 21
                }
            ],
            "seriousEvents": [
                {
                    "term": "colon cancer",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Colectomy for colon cancer diagnosed a week after study completion",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "agitation",
                    "organSystem": "Nervous system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Hospitalization for hallucinations and agitation",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "death",
                    "organSystem": "Nervous system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Ischemic stroke followed by death",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "hallucinations",
                    "organSystem": "Nervous system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Hospitalization for hallucinations and agitation",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "pneumonia",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Pneumonia accompanied by congestive heart failure",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "urinary tract infection",
                    "organSystem": "Renal and urinary disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 3,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "cold symptoms",
                    "organSystem": "General disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "decreased appetite",
                    "organSystem": "General disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "arm or shoulder pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "diarrhea",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "abdominal pain",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "sinusitis",
                    "organSystem": "General disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 1,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 4,
                            "numAffected": 2,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "hallucinations",
                    "organSystem": "Psychiatric disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "anxiety",
                    "organSystem": "Psychiatric disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "paranoia",
                    "organSystem": "Psychiatric disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "cough",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        }
                    ]
                },
                {
                    "term": "agitation",
                    "organSystem": "Psychiatric disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 21
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 21
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Victor Henderson",
                "organization": "Stanford University",
                "email": "vhenderson@stanford.edu",
                "phone": "650-723-5456"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "raloxifene (selective estrogen receptor modulator, SERM)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests raloxifene \u2014 an oral selective estrogen receptor modulator (SERM) \u2014 in women with Alzheimer disease to determine cognitive effects. SERMs act via estrogen receptor modulation (hormone receptor mechanism) rather than directly targeting core AD pathology such as amyloid or tau; therefore this is best classified as a cognitive-enhancement / neuroprotective strategy rather than a disease-targeted anti-amyloid/tau biologic or small-molecule pathology-directed therapy. \ue200cite\ue202turn0search2\ue202turn0search4\ue201",
        "Act: Key trial details \u2014 multisite randomized, raloxifene versus placebo for treatment of women with AD (pilot randomized controlled trial). The published pilot RCT reports no significant cognitive benefit at 12 months in this sample. The intervention and trial description identify raloxifene as the active drug and placebo as control. \ue200cite\ue202turn0search0\ue202turn0search3\ue201",
        "Evidence about raloxifene and cognition: Larger prevention trials (MORE) assessed raloxifene for risk of cognitive impairment and suggested possible reduction in risk of mild cognitive impairment at a higher dose (120 mg), supporting investigation of raloxifene for cognitive outcomes, but the AD treatment pilot trial did not show benefit. These sources describe raloxifene as a SERM rather than an anti-amyloid or anti-tau agent. \ue200cite\ue202turn0search1\ue202turn0search3\ue201",
        "Reflect: Classification check \u2014 raloxifene is a small-molecule SERM but its intended effect in these AD trials is to modify cognition via estrogen receptor\u2013mediated neuroprotective/neurotrophic effects (cognitive improvement), not to target Alzheimer pathology (amyloid/tau) with a biologic or a disease-targeted small-molecule inhibitor. Thus the most appropriate category is 'cognitive enhancer'. No significant ambiguity in the trial description; if you want, I can reclassify only if you prefer to treat SERMs as 'disease-targeted small molecule' (not recommended here). \ue200cite\ue202turn0search2\ue202turn0search3\ue201",
        "Web search results used (titles/sources): 'Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial - PubMed' (pilot RCT). \ue200cite\ue202turn0search0\ue201; 'Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial - PMC' (full text). \ue200cite\ue202turn0search3\ue201; 'Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the MORE randomized trial - PubMed' (MORE prevention trial). \ue200cite\ue202turn0search1\ue201; 'Raloxifene: A Selective Estrogen Receptor Modulator | AAFP' (SERM mechanism/indications). \ue200cite\ue202turn0search2\ue201; 'Raloxifene: A Selective Estrogen Receptor Modulator, Oncologist review' (mechanistic detail). \ue200cite\ue202turn0search4\ue201"
    ],
    "agent_type": "L) Growth Factors and Hormones",
    "explanation_agent": [
        "Reason: The trial tests raloxifene, a selective estrogen receptor modulator (SERM), with the intent of modifying cognition via estrogen receptor\u2013mediated neuroprotective/neurotrophic effects rather than directly targeting core AD pathology (amyloid or tau). This places the mechanism in the hormone/growth-factor domain rather than amyloid, tau, inflammation, or synaptic-only categories. \ue200cite\ue202turn0search1\ue202turn0search2\ue201",
        "Act: Key trial details and mechanism \u2014 the pilot randomized, double-blind, placebo-controlled trial evaluated oral raloxifene (120 mg) versus placebo in women with mild\u2013moderate AD and found no significant cognitive benefit at 12 months; raloxifene\u2019s action is via estrogen receptor modulation (SERM). Based on the described pharmacology and trial goal (cognitive enhancement/neuroprotection via estrogen signaling), assign 'L) Growth Factors and Hormones'. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "Reflect: Verification \u2014 raloxifene is a small\u2011molecule SERM that acts on estrogen receptors (a hormonal signaling pathway). The trial description and published results identify its aim as cognitive/neuroprotective rather than disease-targeted anti-amyloid or anti-tau therapy, so CADRO category L (Growth Factors and Hormones) best fits. If one preferred to classify strictly by drug class (small molecule vs biologic) rather than biological pathway, an alternative could be 'M) Synaptic Plasticity/Neuroprotection', but CADRO's hormone-related mechanisms are captured in L and are more specific here. \ue200cite\ue202turn0search1\ue202turn0search3\ue201",
        "Web search results used as evidence:",
        "- 'Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial' (PubMed) \u2014 trial details and negative primary outcome at 12 months. \ue200cite\ue202turn0search2\ue201",
        "- 'Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The MORE randomized trial' (Am J Psychiatry / PubMed) \u2014 prevention data suggesting dose-dependent effects on risk of MCI/cognitive impairment. \ue200cite\ue202turn0search3\ue202turn0search0\ue201",
        "- 'Raloxifene: A Selective Estrogen Receptor Modulator' (AAFP review) \u2014 mechanism of action and SERM pharmacology (estrogen receptor modulation). \ue200cite\ue202turn0search1\ue201"
    ]
}